• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外分泌功能改变可导致早期胰腺癌的脂肪消耗。

Altered exocrine function can drive adipose wasting in early pancreatic cancer.

机构信息

Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.

Dana-Farber Cancer Institute, Boston, MA, USA.

出版信息

Nature. 2018 Jun;558(7711):600-604. doi: 10.1038/s41586-018-0235-7. Epub 2018 Jun 20.

DOI:10.1038/s41586-018-0235-7
PMID:29925948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6112987/
Abstract

Malignancy is accompanied by changes in the metabolism of both cells and the organism. Pancreatic ductal adenocarcinoma (PDAC) is associated with wasting of peripheral tissues, a metabolic syndrome that lowers quality of life and has been proposed to decrease survival of patients with cancer. Tissue wasting is a multifactorial disease and targeting specific circulating factors to reverse this syndrome has been mostly ineffective in the clinic. Here we show that loss of both adipose and muscle tissue occurs early in the development of pancreatic cancer. Using mouse models of PDAC, we show that tumour growth in the pancreas but not in other sites leads to adipose tissue wasting, suggesting that tumour growth within the pancreatic environment contributes to this wasting phenotype. We find that decreased exocrine pancreatic function is a driver of adipose tissue loss and that replacement of pancreatic enzymes attenuates PDAC-associated wasting of peripheral tissues. Paradoxically, reversal of adipose tissue loss impairs survival in mice with PDAC. When analysing patients with PDAC, we find that depletion of adipose and skeletal muscle tissues at the time of diagnosis is common, but is not associated with worse survival. Taken together, these results provide an explanation for wasting of adipose tissue in early PDAC and suggest that early loss of peripheral tissue associated with pancreatic cancer may not impair survival.

摘要

恶性肿瘤伴随着细胞和机体代谢的变化。胰腺导管腺癌 (PDAC) 与周围组织的消耗有关,这是一种代谢综合征,降低了生活质量,并被提出降低癌症患者的生存率。组织消耗是一种多因素疾病,针对特定的循环因子来逆转这种综合征在临床上大多无效。在这里,我们表明,在胰腺癌的发展过程中,脂肪组织和肌肉组织的丢失很早就发生了。使用 PDAC 的小鼠模型,我们表明,胰腺内的肿瘤生长而不是其他部位的肿瘤生长导致脂肪组织消耗,这表明胰腺内环境中的肿瘤生长导致了这种消耗表型。我们发现,外分泌胰腺功能的降低是脂肪组织丢失的驱动因素,而胰腺酶的替代可以减轻 PDAC 相关的外周组织消耗。矛盾的是,脂肪组织损失的逆转会损害 PDAC 小鼠的生存。在分析 PDAC 患者时,我们发现,在诊断时脂肪组织和骨骼肌组织的消耗很常见,但与较差的生存无关。总之,这些结果为早期 PDAC 中脂肪组织消耗提供了解释,并表明与胰腺癌相关的外周组织的早期丢失可能不会损害生存。

相似文献

1
Altered exocrine function can drive adipose wasting in early pancreatic cancer.外分泌功能改变可导致早期胰腺癌的脂肪消耗。
Nature. 2018 Jun;558(7711):600-604. doi: 10.1038/s41586-018-0235-7. Epub 2018 Jun 20.
2
Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.转录激活因子 3 信号驱动肝通过抑制酮体生成促进早期胰腺癌恶病质
J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):975-988. doi: 10.1002/jcsm.13466. Epub 2024 Apr 17.
3
Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.三种恶病质表型及在 FOLFIRINOX 治疗胰腺癌中仅脂肪丢失对生存的影响。
J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):673-684. doi: 10.1002/jcsm.12307. Epub 2018 Jul 5.
4
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.脂肪组织和骨骼肌减少先于胰腺癌的临床诊断。
Nat Commun. 2023 Jul 18;14(1):4317. doi: 10.1038/s41467-023-40024-3.
5
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling.胰腺导管腺癌恶病质中内脏脂肪组织重塑:激活素 A 信号的作用。
Sci Rep. 2022 Jan 31;12(1):1659. doi: 10.1038/s41598-022-05660-7.
6
Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.肿瘤来源的 IL-6 和肿瘤、脂肪和肌肉之间的转信号介导胰腺癌恶病质。
J Exp Med. 2021 Jun 7;218(6). doi: 10.1084/jem.20190450.
7
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.胰腺癌的系统性激活素反应:对有效癌症恶病质治疗的启示。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1083-1101. doi: 10.1002/jcsm.12461. Epub 2019 Jul 8.
8
Establishment and characterization of a novel murine model of pancreatic cancer cachexia.建立并鉴定一种新型胰腺癌恶病质小鼠模型。
J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):824-838. doi: 10.1002/jcsm.12225. Epub 2017 Jul 20.
9
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.胰腺癌恶病质表型、机制和治疗在小鼠和人类中的性别特异性:激活素的作用。
J Cachexia Sarcopenia Muscle. 2022 Aug;13(4):2146-2161. doi: 10.1002/jcsm.12998. Epub 2022 May 5.
10
Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.血清胰岛素样生长因子结合蛋白 2 水平作为与胰腺导管腺癌相关的营养不良和肌肉减少症的生物标志物。
J Cachexia Sarcopenia Muscle. 2021 Jun;12(3):704-716. doi: 10.1002/jcsm.12692. Epub 2021 Mar 24.

引用本文的文献

1
An alternative route for β-hydroxybutyrate metabolism supports cytosolic acetyl-CoA synthesis in cancer cells.β-羟基丁酸代谢的另一条途径支持癌细胞中胞质乙酰辅酶A的合成。
Nat Metab. 2025 Sep 8. doi: 10.1038/s42255-025-01366-y.
2
Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer.单细胞和转录组分析揭示了PCDH17在胰腺癌非炎症性肿瘤微环境中的作用。
Front Endocrinol (Lausanne). 2025 May 23;16:1559909. doi: 10.3389/fendo.2025.1559909. eCollection 2025.
3
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.

本文引用的文献

1
Establishment and characterization of a novel murine model of pancreatic cancer cachexia.建立并鉴定一种新型胰腺癌恶病质小鼠模型。
J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):824-838. doi: 10.1002/jcsm.12225. Epub 2017 Jul 20.
2
Supportive care in pancreatic ductal adenocarcinoma.胰腺导管腺癌的支持性治疗。
Clin Transl Oncol. 2017 Nov;19(11):1293-1302. doi: 10.1007/s12094-017-1682-6. Epub 2017 Jun 13.
3
Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.肿瘤诱导的白细胞介素-6重编程宿主代谢以抑制抗肿瘤免疫。
靶向突变型p53依赖的胰腺癌中的NPY/NPY1R信号轴会损害转移。
Sci Adv. 2025 Mar 14;11(11):eadq4416. doi: 10.1126/sciadv.adq4416. Epub 2025 Mar 12.
4
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations.欧洲胰腺外分泌功能不全诊断与治疗指南:UEG、EPC、EDS、ESPEN、ESPGHAN、ESDO和ESPCG基于证据的建议。
United European Gastroenterol J. 2025 Feb;13(1):125-172. doi: 10.1002/ueg2.12674. Epub 2024 Dec 5.
5
Genetics and biology of pancreatic ductal adenocarcinoma.胰腺导管腺癌的遗传学与生物学
Genes Dev. 2025 Jan 7;39(1-2):36-63. doi: 10.1101/gad.351863.124.
6
Integrative study of skeletal muscle mitochondrial dysfunction in a murine pancreatic cancer-induced cachexia model.骨骼肌线粒体功能障碍在小鼠胰腺癌恶病质模型中的综合研究。
Elife. 2024 Oct 18;13:RP93312. doi: 10.7554/eLife.93312.
7
A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution.单细胞分辨率揭示癌症恶病质诱导的肌肉萎缩的分子途径。
Cell Rep. 2024 Aug 27;43(8):114587. doi: 10.1016/j.celrep.2024.114587. Epub 2024 Aug 7.
8
Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma.利用真实世界数据预测初治胰腺导管腺癌患者种族和民族多样化的多机构队列中的癌症恶病质阶段、生活质量和生存率。
Front Oncol. 2024 Jul 23;14:1362244. doi: 10.3389/fonc.2024.1362244. eCollection 2024.
9
Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration.通过跨学科合作确定并解决癌症恶病质的研究重点
Cancers (Basel). 2024 Jun 27;16(13):2364. doi: 10.3390/cancers16132364.
10
The role of biomarkers in the early detection of pancreatic cancer.生物标志物在胰腺癌早期检测中的作用。
Fam Cancer. 2024 Aug;23(3):309-322. doi: 10.1007/s10689-024-00381-4. Epub 2024 Apr 25.
Cell Metab. 2016 Nov 8;24(5):672-684. doi: 10.1016/j.cmet.2016.10.010.
4
Lipid Extraction from Mouse Feces.从小鼠粪便中提取脂质。
Bio Protoc. 2015 Jan 5;5(1). doi: 10.21769/bioprotoc.1375.
5
Mechanisms of metabolic dysfunction in cancer-associated cachexia.癌症恶病质相关代谢功能障碍的机制。
Genes Dev. 2016 Mar 1;30(5):489-501. doi: 10.1101/gad.276733.115.
6
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?癌症恶病质中导致骨骼肌质量丢失的分子途径——动物模型的研究结果能否应用于人类?
BMC Cancer. 2016 Feb 8;16:75. doi: 10.1186/s12885-016-2121-8.
7
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.骨骼肌消耗可预测晚期胰腺癌患者接受姑息化疗的预后,与体重指数无关。
PLoS One. 2015 Oct 5;10(10):e0139749. doi: 10.1371/journal.pone.0139749. eCollection 2015.
8
The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.肌肉减少症和肌脂肪变性对不可切除胰腺癌或远端胆管癌预后的影响。
Clin Nutr. 2016 Oct;35(5):1103-9. doi: 10.1016/j.clnu.2015.08.005. Epub 2015 Sep 1.
9
The Lipid Droplet Protein Hypoxia-inducible Gene 2 Promotes Hepatic Triglyceride Deposition by Inhibiting Lipolysis.脂滴蛋白低氧诱导基因2通过抑制脂肪分解促进肝脏甘油三酯沉积。
J Biol Chem. 2015 Jun 12;290(24):15175-84. doi: 10.1074/jbc.M115.650184. Epub 2015 Apr 28.
10
Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis.热量限制、生酮饮食和间歇性禁食在动物模型中癌症起始、进展和转移过程中的作用:一项系统综述和荟萃分析。
PLoS One. 2014 Dec 11;9(12):e115147. doi: 10.1371/journal.pone.0115147. eCollection 2014.